Food & Drug Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Food & Drug Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Dokuz Eylul University
Report describes upper extremity deep vein thrombosis
September 24th, 2004
The clinical and treatment characteristics of upper extremity deep vein thrombosis were the focus of a recent report. According to the report, published in the Journal of International Medical Research, "We aimed to evaluate patients with upper extremity deep vein thrombosis (UEDVT) in terms of the risk factors, symptoms, clinical course, diagnostic approaches and treatment outcome." O. Karabay and colleagues of Dokuz Eylul University described their study, "Thirty-six patients with a diagnosis of UEDVT, comprising 19 males (52.7%) and 17 females (47.3%), were included in the study; the mean (±SD) age was 54 ± 12.3 years. The...
Source: Food & Drug Law Weekly (2004-09-24)
|
